Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; medical services in the areas of gynecology, urology, and internal medicine; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, and real estate development and operation activities. Jinxin Fertility Group Limited was founded in 2003 and is headquartered in Chengdu, China.

Mr. Yong  Zeng

Senior Vice President

Ms. Hanmei  Huang

Chief Financial Officer

Ms. Pu  Shi

Vice President and Head of Human Resources & Administration

Mr. Yong  Zhong

Executive Chairman of the Board

Dr. Ling  Chi

Chief Scientific Officer

Mr. Yang  Dong

Co-Chief Executive Officer & Executive Director

Ms. Rong  Lyu

CO-Chief Executive Officer & Executive Director

Dr. John G.  Wilcox FACOG, M.D.

Executive Director

Dr. Lihong  Geng

Chief Medical Quality Control Officer & Executive Director

Ms. Hongkun  Liu

Vice President & Head of Strategic Investment

Jinxin Fertility Group Limited

Jinxin Fertility Group Limited Ledningsstruktur

Information om ledningen